Company / EPS (Basic)
OMEROS CORP EPS (Basic) History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$2.70
FY2024
5-year range
-$2.70 / $3.12
FY2021-FY2024
Trend
-43.6%
vs FY2023
Sector context
#147 of 208
Health Care
What the data says
At $-2.70, OMEROS CORP's eps (basic) ranks #147 of 208 in the Health Care sector. EPS (Basic) has declined for 3 consecutive years, from $3.12 in FY2021 to $-2.70 in FY2024.
Based on SEC 10-K filings.
-2.70 in FY2024.
Declined from $0.76 to $-2.70 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#147 of 208 in Health CareTop 71% of 208This company -$2.70 Sector average -$0.96
▼
-180.3% below sector average
Key checks
Key Insights
- OMEROS CORP's eps (basic) has declined for 3 consecutive years.
- In FY2024, eps (basic) decreased 43.6% year-over-year.
- Ranks #147 out of 208 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$2.70 | -43.6% |
| FY2023 | -$1.88 | -347.4% |
| FY2022 | $0.76 | -75.6% |
| FY2021 | $3.12 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026